Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Li Auto Inc (LI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Li Auto Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.13 (market cap $3.94B), while Li Auto Inc trades at $11.3 (market cap $11.27B). The key difference: Li Auto Inc is far larger — about 2.9× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Li Auto Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Li Auto Inc for 102 Days on average.
| EWTX | LI | |
|---|---|---|
Market Cap | $3.94B | $11.27B |
Volume | 810,104 | 3,921,121 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $22.72 |
52-Week Low | $14.89 | $10.69 |
Typical Hold Time | 0 Days | 102 Days |
Enterprise Value | $3.48B | $673.48M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Li Auto (LI) trades at $11.75, up 3.07% today but near 52-week lows amid declining delivery volumes and negative earnings surprises. The stock shows bearish technical signals with mixed analyst sentiment (43.75% buy, 50% hold). Recent Q2 2026 results missed expectations with a net loss, though vehicle margins improved to 9.4%. New model launches (Li i9, MEGA) and global expansion plans contrast with cash burn concerns, with operating cash flow negative $8.6B in 2025.
Outlook remains challenged by intense EV competition and China's auto market slowdown, but the company's strong balance sheet ($112.8B cash) provides cushion. Analyst consensus target of $15.18 suggests 29% upside if execution improves, though near-term risks from volume pressure and margin compression persist. The stock offers value at 0.78 P/S but requires monitoring of delivery trends and cost controls.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Li Auto Inc
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →
